Klcm Advisors, Inc. Amgen Inc Transaction History

Klcm Advisors, Inc.

$820 Million
Q3 2024

A detailed history of Klcm Advisors, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Klcm Advisors, Inc. holds 943 shares of AMGN stock, worth $264,049. This represents 0.04% of its overall portfolio holdings.

Number of Shares

943

Previous 869 8.52%

Holding current value

$264,049

Previous $271,000 11.81%

% of portfolio

0.04%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$309.38 - $337.38 $22,894 - $24,966	74 Added 8.52%	943 $303,000
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $2,102 - $2,554	8 Added 0.93%	869 $271,000
Q1 2024 May 16, 2024	BUY	$268.87 - $324.56 $9,679 - $11,684	36 Added 4.36%	861 $244,000
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $46,793 - $52,788	-183 Reduced 18.15%	825 $237,000
Q3 2023 Nov 07, 2023	BUY	$218.65 - $271.46 $10,932 - $13,572	50 Added 5.22%	1,008 $270,000
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $205,270 - $242,728	958 New	958 $212,000
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $182,536 - $231,934	797 New	797 $209,000
Q2 2021 Aug 03, 2021	SELL	$233.58 - $259.14 $189,900 - $210,680	-813 Closed	0 $0
Q1 2021 Apr 21, 2021	BUY	$221.91 - $258.6 $180,412 - $210,241	813 New	813 $202,000
Q4 2020 Jan 26, 2021	SELL	$216.38 - $257.67 $170,507 - $203,043	-788 Closed	0 $0
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $184,904 - $205,628	788 New	788 $200,000
Q2 2018 Aug 09, 2018	SELL	$166.05 - $186.51 $421,600 - $473,548	-2,539 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $38,968 - $45,540	-230 Reduced 8.31%	2,539 $433,000
Q4 2017 Feb 15, 2018	BUY	$168.79 - $188.59 $10,802 - $12,069	64 Added 2.37%	2,769 $482,000
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $51,023 - $58,255	305 Added 12.71%	2,705 $504,000
Q2 2017 Aug 15, 2017	BUY	N/A	2,400	2,400 $413,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klcm Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Klcm Advisors, Inc. with notifications on news.

Account

Klcm Advisors, Inc. Amgen Inc Transaction History